Multiple sclerosis therapeutics cohen jeffrey a rudick richard a. Multiple sclerosis therapeutics (Book, 2003) [kongouji.com] 2019-03-14

Multiple sclerosis therapeutics cohen jeffrey a rudick richard a Rating: 6,2/10 533 reviews

Multiple Sclerosis Therapeutics von Richard A. Rudick auf kongouji.com

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

Measures of gadolinium enhancement, T1 black holes and T2-hyperintense magnetic resonance imaging in multiple sclerosis. Interferons in secondary progressive multiple sclerosis. Use of cyclophosphamide and other immunosuppressants to treat multiple sclerosis. Rehabilitation in multiple sclerosis patients. Stem cell transplantation for multiple sclerosis. The fourth edition has been extensively revised, featuring more than 50% new material. This excellent and well written book, based on recent progress in basic sciences, clinics, neuroimaging and pharmacology, is a highly useful resource for neurologists and anyone involved in the treatment of multiple sclerosis.

Next

Multiple Sclerosis Therapeutics

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

The fourth edition has been extensively revised, featuring more than 50% new material. This edition reflects current understanding of the pathophysiology of the disease and includes popular and emerging treatments. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. Measures of neurological impairment and disability in multiple sclerosis. Aspects of multiple sclerosis that relate to trial design and clinical management.

Next

Multiple Sclerosis Therapeutics

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

Assessment of neuropsychological function in multiple sclerosis. Ethical considerations in multiple sclerosis clinical trials. Management of bladder and sexual dysfunction in multiple sclerosis. The fourth edition has been extensively revised, featuring more than 50% new material. Rehabilitation in multiple sclerosis patients. Measures of neurological impairment and disability in multiple sclerosis.

Next

Multiple Sclerosis Therapeutics, 3rd Edition : Journal of Neuro

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

Neutralizing antibodies directed against interferon A. Management of spasticity in multiple sclerosis. Functional imaging in multiple sclerosis. High-dose methylpredisolone in the treatment of multiple sclerosis. Recommended Audience: Practicing neurologists and residents in training, rehabilitation specialists, radiologists, and neuro-immunologists will find this book useful.

Next

Multiple Sclerosis Therapeutics, 3rd Edition : Journal of Neuro

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

Health-related quality of life assessment in multiple sclerosis. Assessment of neuropsychological function in multiple sclerosis. Although immunosuppressive treatments continue to be developed and refined, more targeted immunomodulatory therapies are surfacing as we learn more about how the immune system works in health and disease. Chemokines and central nervous system inflammation: relevance to multiple sclerosis. This new edition has been thoroughly revisited, reorganized and amended by a team of international expert contributors. Measurement of central nervous system atrophy in multiple sclerosis.

Next

Multiple Sclerosis Therapeutics : Jeffrey A. Cohen : 9781841845258

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. Biological concepts of multiple sclerosis pathogenesis and relationship to treatment. Strengths: This book is very comprehensive in scope and includes excellent illustrations and instructive tables. The book is divided into 4 sections. Measures of magnetization transfer in multiple sclerosis. Pharmacogenetics and pharmacogenomics in multiple sclerosis. Use of cyclophosphamide and other immunosuppressants to treat multiple sclerosis.

Next

Multiple Sclerosis Therapeutics

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. Sinopse This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. Alternative designs for multiple sclerosis clinical trials. Sex hormones and other pregnancy-related factors with therapeutic potential in multiple sclerosis. Magnetic resonance imaging of pathway-specific structure and function in multiple sclerosis.

Next

Multiple sclerosis therapeutics (eBook, 2011) [kongouji.com]

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

Treatment of pain, paresthesias and paroxysmal disorders in multiple sclerosis. Optical coherence tomography to monitor neuronal integrity in multiple sclerosis. Selection and interpretation of end-points in multiple sclerosis clinical trials. A second problem, which is unavoidable given the rapid expansion of data in this field, is that some information is already outdated. Rudick ; prefaces written by Henry McFarland. The fourth edition has been extensively revised and features more than 50% new material.

Next

Multiple sclerosis therapeutics (eBook, 2011) [kongouji.com]

multiple sclerosis therapeutics cohen jeffrey a rudick richard a

Measurement of central nervous system atrophy in multiple sclerosis. Disease-modifying therapy for multiple sclerosis in clinical practice. Magnetic resonance imaging of pathway-specific structure and function in multiple sclerosis. T cell-based therapies in multiple sclerosis. Journal European Journal of Neurology — Wiley Published: Feb 1, 2009. Axonal pathology in patients with multiple sclerosis: evidence from in vivo proton magnetic resonance spectroscopy.

Next